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http:WHAT THIS PAPER ADDS?
The impact of thoracic aortic endovascular repair (TEVAR) on vascular surgical practice and workload has not
been assessed previously. Using routine data, this paper shows an escalating use of TEVAR for repair of
descending thoracic aortic dissections and aneurysms, in the absence of any known beneﬁt of TEVAR on patient
survival.Objectives: To investigate population trends in thoracic aortic disease (dissections and aneurysms) in England
and Wales, with focus on the impact of thoracic endovascular aortic repair on procedure numbers and age at
repair.
Materials and methods: Routine hospital statistics of England and Wales provided admission, procedure and
mortality data from 1999 to 2010. All data were age-standardised, reported per 100,000 population, by age
bands (>50 years or 50e74 years versus 75þ years) and gender. Only patients 50þ years were included, to focus
on degenerative disease.
Results: Between 1999 and 2010 hospital admissions for total (ascending and descending) have risen steadily for
thoracic aortic dissection (TAD) from 7.2 to 8.8 and thoracic aortic aneurysm (TAA) from 4.4 to 9.0, principally
attributable to increased admissions in those 75þ years. Total mortality declined steadily over the same period,
for TAD from 4.4 to 3.2 and for TAA from 10.4 to 7.5. Procedure rates have risen sharply, driven by the
implementation of TEVAR from 2006, for type B dissection from 0.06 to 0.53 and for descending TAA from 0.76
to 1.89. All ﬁgures are per 100,000 population with P <0.005.
Conclusion: Improvements in case ascertainment may have contributed to the increase in hospital admissions.
The increased application of TEVAR, particularly for dissections, is mainly in those above 75 years and has not yet
translated into an accelerated survival beneﬁt.
 2012 European Society for Vascular Surgery. European Society for Vascular Surgery. Published by Elsevier Ltd.
All rights reserved.
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Degenerative aneurysms develop throughout the aorta.
The incidence and prevalence rates of abdominal aortic
aneurysms (AAA), the commonest aortic aneurysm, have
been assessed more widely than those for thoracic aortic
aneurysms (TAA), thoracoabdominal aneurysms or thoracic
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//dx.doi.org/10.1016/j.ejvs.2012.12.007incidence, prevalence and natural history of thoracic aortic
pathology, which previously has been far less common than
abdominal aneurysm. Recent improvements in thoracic
imaging, with widespread application, are likely to lead to
a continuing increase in case ascertainment of TAA.1
Very recently, screening studies from different parts of
the world have shown a substantial decrease of AAA prev-
alence to less than 2% in men aged 65 years and there is
evidence that the incidence of ruptured aneurysm and
mortality from AAA also are declining.2e4 Screening pro-
grammes were implemented too late to explain these
decreases and the reasons for change are multifactorial,
including the introduction of endovascular repair and risk
factor management, particularly the rapidly declining
proportion of the older population who continue to smoke.5
In addition, the disease burden for abdominal aortic aneu-
rysm has shifted to the oldest age group (75 years).
Table 1b. Procedural codes for thoracic aortic dissections.
L20.2 Emergency bypass of segment of thoracic aorta
L21.2 Bypass of segment of thoracic aorta
L27.4 Endovascular insertion of stent graft for aortic
dissection
L28.4 Endovascular stenting for aortic dissection
R.S. von Allmen et al. 155Similarly, the age standardised mortality for myocardial
infarction has fallen by almost half between 2002 and 2010,
due to a decline in event rate as well as improved survival.6
For TAA, incidence and prevalence studies are scarce and
data are rarely separated into ascending and descending
aortic pathologies, even though the treatment options and
outcomes vary considerably according to anatomical loca-
tion and pathology of the disease. Various studies since the
early 1980s have indicated an increase in the incidence rate
of thoracic disease, though each study focused on assessing
a different thoracic aortic pathology.1,7,8 At the beginning of
the 21st century, open surgical repair was the default
corrective procedure for TAA and occasionally used for TAD.
Since then, thoracic endovascular repair (TEVAR) has been
implemented and evaluated in device registries9e11 with its
use becoming widespread, particularly for the management
of descending aortic disease. Nevertheless, there is
evidence that TEVAR may be used in older and frailer
patients, without any survival beneﬁt.12
The aim of this study is to determine and investigate
recent hospital trends and mortality from thoracic aortic
disease (both TAA and TAD) in England and Wales.METHODS
Routine hospital data from 1999 to 2010 were provided by
Hospital Episodes Statistics (HES) (England) and Health
Solutions Wales PEDW Statistics (Wales). The HES database
is a record level database of hospital admissions in English
National Health Service (NHS) hospitals. Data years run from
April of the named year to March of the following year.
Mortality data were obtained for England and Wales
from 1979 to 2010, from the UK Ofﬁce for National Statis-
tics, which gather all death data of residents in England and
Wales. Data years run from January to December of the
named year. The diagnoses/mortality codes used were ob-
tained from the tenth revision of the International Classi-
ﬁcation of Diseases (ICD 10). These were; dissection of aorta
(I71.0); thoracic aortic aneurysm ruptured (I71.1); thoracic
aortic aneurysm without mention of rupture (I71.2). Codes
for thoracoabdominal aortic aneurysm ruptured (I71.5) and
thoracoabdominal aortic aneurysm without mention of
rupture (I71.6) were not included. Mortality covers all
mortality, without separation of whether this is in or out of
hospital.
Data for hospital procedures were also obtained from
Hospital Episode Statistics and Health Solutions Wales
PEDW Statistics, for England and Wales respectively. TheseTable 1a. Procedural codes for thoracic aortic aneurysms.
L18.2 Emergency replacement aneurysmal segment of
thoracic aorta
L19.2 Other replacement of aneurysmal segment of
thoracic aorta
L27.3 Endovascular insertion of stent graft for thoracic
aortic aneurysm
L28.3 Endovascular stenting for thoracic aortic
aneurysmare coded according to the fourth revision of the Classiﬁ-
cation of Interventions and Procedures (OPCS-4), and were
used to identify thoracic aortic repairs (Tables 1a and 1b).
Ascending aortic procedural codes were included to calcu-
late total thoracic aortic admissions and mortality, since
TAA and TAD admissions and mortality data are not avail-
able separated by ascending and descending codes. All
abdominal aortic aneurysm codes were excluded from
mortality, hospital episodes and procedures data. Aneurysm
of unspeciﬁed sites also were excluded as aortic aneurysm
of unspeciﬁed site tends to be at the abdominal site.13
Age and sex speciﬁc population based mortality, hospital
admissions and procedures were used to calculate age-
standardised mortality, admission and procedure rates at
each yearly interval. All data were age-standardised, re-
ported per 100,000 population, by age bands (50 years,
50e74 years and 75 years) and by gender. Only patients
aged 50 years and above were included in order to focus on
patients with degenerative disease and minimise the
numbers with connective tissue disorders. The number of
deaths, admissions and procedures were used as the
numerators and the total corresponding age thresholds
were used as the denominators to calculate deaths,
admissions and procedures per 100,000 population.
Trends in different age bands and gender were assessed
by linear regression analysis using the Comprehensive R
Archive Network. An alpha level of 0.05 was chosen to
determine statistical signiﬁcance of differences.
RESULTS
Mortality trends
The age-standardised mortality was estimated for TAA and
TAD in England and Wales from 1979 to 2010. A modestFigure 1. Age standardised mortality for thoracic aortic aneurysm
(solid grey line) and thoracic aortic dissection (solid black line) in
England and Wales 1979e2010, by gender. Data were stand-
ardised from above the age of 50 years for total deaths of ICD9/10
codes; 441.1,2/I71.1,2 (TAA) and 441.0/I71.0 (TAD).
Figure 3. Admissions for thoracic aortic dissection in England and
Wales 1999e2010, by age. TAD admissions; 50e74 years (solid
grey line), 75þ years (solid black line). Data were standardised by
age group for ICD 10 codes; I71.0 (dissection of aorta, any part).
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and TAA and there was a signiﬁcant decline thereafter, the
decline being more marked for TAD (Fig. 1). Since 1999 (the
ﬁrst year of hospital admissions and procedures reporting),
age standardised mortality for TAD has decreased steadily
from 10.39 to 7.47 (P< 0.0001) and for TAA from4.39 to 3.18
(P < 0.0001) deaths per 100,000 population. The rate of
decline in mortality for both TAA and TAD was similar in men
and women. For TAA, in men mortality declined from 3.7 to
2.3 (P < 0.0001) and in women from 5.0 to 3.9 (P < 0.0001)
per 100,000 population. For TAD, in men mortality declined
from 10.0 to 7.0 (P< 0.0001) and in women from 10.8 to 7.9
(P < 0.0001) per 100,000 population.
Admissions 1999e2010
The age-standardised admissions for TAA from 1999 to
2010, separated into ruptures and non-rupture admissions,
are shown by age bands in Fig. 2. Overall hospital admis-
sions have risen from 4.4 to 9.0 (P < 0.0001). Whilst the
rate of emergency admissions for rupture has changed little,
there has been a steady increase in admissions for intact
aneurysm since 2001, particularly among those 75þ years
of age.
Age-standardised admissions for TAD have risen from 7.2
to 8.8 per 100,000 population (P ¼ 0.0001) over the same
period (Fig. 3).
For TAA, the increase in admissions was similar in men
(5.5e10.8, P < 0.0001), and women (3.4e7.4, P < 0.0001)
per 100,000 population respectively. For TAD, the increase
in admissions also was similar for men and women, men
from 10.1 to 12.2 (P ¼ 0.023) and women from 4.7 to 5.8
(P ¼ 0.0002) per 100,000 population.
Descending aortic repairs
Procedure codes permit the separation of repairs for
ascending and descending aortic disease. Since the sepa-
rate coding of open repair and TEVAR from 2006 forward,
the rate of repairs for descending TAA has more thanFigure 2. Admissions for non-ruptured and ruptured thoracic aortic
aneurysm in England and Wales 1999e2010, by age. Non-ruptured
TAA admissions; 50e74 years (solid grey line), 75þ years (solid
black line), ruptured TAA admissions 50e74 years (dashed grey
line), 75þ years (dashed black line). Data were standardised from
above the age of 50 years separated by the following ICD 10 codes;
I71.1 (ruptured TAA) and I71.2 (non-ruptured TAA).doubled. In 2005, the overall rate of repairs was 0.7 versus
1.9 per 100,000 population in 2010. The most marked
increase has been in those aged 75þ years (Fig. 4). Whilst
the rate of open repairs has been fairly steady, the
increases are entirely attributable to the increased rate of
TEVAR (Fig. 4).
The changes for type B aortic dissection are even more
remarkable. Overall, repairs have increased from 0.1 in 2000
to 0.5 per 100,000 population (P ¼ 0.0001) in 2010. Again,
the most accentuated changes have been in those 75þ
years, where rates of repair have increased about 30-fold
(Fig. 5).
For TAA, both men and women have beneﬁted similarly
from the increased rate of TEVAR (Fig. 6). TEVAR procedures
have risen since 2006 from 0.65 to 1.71 (P ¼ 0.001) and
from 0.24 to 0.83 (P ¼ 0.004) per 100,000 population in
men and women, respectively.
In contrast, for TAD, men tend to have beneﬁted more
than women from the increased application of TEVAR
(Fig. 6). Since 2006 TEVAR procedures for TAD have
increased in men from 0.31 to 0.83 per 100,000 population
(P ¼ 0.072) and in women from 0.13 to 0.17 per 100,000
population (P ¼ 0.339).Figure 4. Repairs for descending thoracic aortic aneurysm in
England and Wales 1999e2010, by age. TAA open repairs (solid
grey bars) and TEVARs (solid black bars); 50e74 years on the left
hand side and 75þ years on the right hand side. Data were
standardised by age group for procedural codes; L18.2, L19.2,
L20.2, L21.2 (open repair), L27.3, L28.3 (TEVAR).
Figure 5. Repairs for descending thoracic aortic dissection in
England and Wales 1999e2010, by age. TAD open repairs (solid
grey bars) and TEVARs (solid black bars); 50e74 years on the left
hand side and 75þ years on the right hand side. Data were
standardised by age group for procedural codes; L20.2, L21.2
(open repair), L27.4, L28.4 (TEVAR).
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This century, mortality from thoracic aortic diseases has
been declining, shadowing the trend of other cardiovascular
diseases such as myocardial infarction and abdominal aortic
aneurysm.2,3,6,14,15 In contrast, population hospital admis-
sion rates have been rising steadily, particularly among
those 75þ years of age. The most notable change is the
rapid increase in descending aortic repairs since the intro-
duction of TEVAR, particularly for type B aortic dissections.
One direct interpretation of these ﬁgures is that increased
admission and procedure rates are incurring an increased
cost burden for the care of thoracic aortic disease.
Mortality for both aneurysm and dissection is decreasing
steadily, however the decrease started well ahead of imple-
mentation of TEVAR and does not appear to have been
accelerated by the rapid rise of TEVAR procedures. It is very
likely that the underlying decline in mortality is associated
with improvements inmanagement of cardiovascular risks, in
line with trends for other cardiovascular diseases, i.e.
abdominal aortic aneurysm and myocardial infarction.6,13Figure 6. Total repairs for descending thoracic aortic aneurysm (left
hand side) and descending thoracic aortic dissection (right hand
side) in England and Wales 1999e2010, by gender. Men (solid grey
bars), women (solid black bars). Data were standardised by gender
for procedural codes; L18.2, L19.2, L20.2, L21.2, L27.3, L28.3 (TAA)
and L20.2, L21.2, L27.4, L28.4.Coroner post-mortem rates in England and Wales (which
review all sudden deaths) have remained unchanged during
the recent period of study,16 hencemortality data are unlikely
to have been inﬂuenced signiﬁcantly by changes in cause of
death ascertainment.
Since admission reporting started in 1999, admissions for
both TAA and TAD have been increasing, with an almost
2-fold increase for TAA. This increase in admission rates
preceded the implementation of TEVAR by several years.
TAA are in most cases asymptomatic and diagnosis is
dependent on computerised tomography, cardiac ultra-
sound or magnetic resonance imaging. Today, computerised
tomography of the thorax is widely used in clinical settings,
to contribute to an increasing incidental detection rate of
asymptomatic aortic aneurysms.1 Probably, this increase in
ascertainment rate has translated into the observed
increased in admission rates for TAA. Conversely, patients
suffering from TAD most often present with clinical symp-
toms leading to diagnosis. Hence, case ascertainment is not
as important an issue as is for TAA, so that the increase in
admission rate has been less marked for TAD than TAA.
A large nationwide population-based Swedish study of
aneurysm and dissection of the ascending and descending
aorta suggested an increase in incidence rate of thoracic
aortic disease since 1987, from 10.7 per 100,000 per year to
16.3 per 100,000 per year in 2002. This increase in incidence
was associated with an increase in aortic repairs, initially
the increase in thoracic aortic repairs was slow and only
accelerated from 1996 onwards.1 It is important to note
that probably very few subjects in this Swedish study
underwent TEVAR procedures, since 2002 was before the
publication of ﬁrst TEVAR device validation studies in
2004e2006.11,17e20 Population-based data about TAA and
TAD are scarce and no other up-to-date population-based
study has been published covering the time since the more
widespread implementation of TEVAR.
This study in England and Wales shows a meteoric
increase in procedure rates for descending aortic disease,
particularly for TAD, driven by the use of TEVAR. The
increase in repairs was most marked in the oldest age
group, those 75þ years, with a 3-fold increase for TAD and
an almost 2-fold increase for TAA procedures. The treat-
ment burden for thoracic aortic aneurysm and dissections
appears to have shifted apparently to the oldest age group,
as has been observed for abdominal aortic aneurysm.13
Although mortality is not separated into ascending versus
descending pathologies, the increase in TEVAR procedures
does not appear to have accelerated the steady underlying
trend of decreasing mortality. Given the current ﬁndings, in
the future we plan to proceed to analyse linked data, in
which mortality, co-morbidities, admission and procedure
data are joined to assess the speciﬁc effects of TEVAR on
mortality. This will permit reporting of in-hospital mortality
and mortality rates after either open or endovascular repair.
The present routine data for England and Wales do not
reveal the impact of frailty on procedures and procedural
mortality. However, there is recent evidence that the exis-
tence of several co-morbidities predicts a high one-year
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Moreover, Medicare data suggest that patients selected for
TEVAR have even worse mid-term survival than patients
selected for open repair and this difference remained robust
even after applying a propensity score matched method
aimed at providing unbiased estimates of treatment
effects.12 Consequently, patient selection seems to be the
determining factor, particularly for mid- and long-term
outcomes following TEVAR.
This study has several limitations, which need to be
highlighted. First, available mortality and admission data are
based on ICD9/10-codes and therefore the data are not
separable by descending and ascending aortic disease.
Second, endovascular procedures are not coded as elective
or urgent cases nor with regard to localisation (ascending
versus descending aorta); however for thoracic aortic
aneurysms urgent cases are likely to be less than 5% of the
total and the number of endovascular repairs for ascending
aortic pathologies remain few. Third, procedures for
dissections do not indicate the urgency of the procedure.
Fourth, current data are not linked to individual patients;
the ratio of admissions to repairs is difﬁcult to interpret.
Last, coding errors are inherent in population-based studies
and may introduce speciﬁc confounders into the analysis.
Nevertheless, the changing trends for admissions and
procedures are apparent and these ﬁgures implicate a great
increase in future vascular workload. Furthermore, the
endovascular techniques, which have broadened the
vascular armamentarium, also challenge education and
training requirements in vascular surgery.
Finally, it is important to realise that TEVAR, unlike endo-
vascular repair of abdominal aortic aneurysm, is still a practice
without a solid evidence base. There are a few randomised
controlled trials aimed at understanding the role of TEVAR for
aortic dissections, but there are none for thoracic aortic
aneurysms. The Investigation of Stent Grafts in Aortic Dissec-
tion (INSTEAD) trial comparing TEVAR with optimum medical
management in uncomplicated sub-acute to chronic type B
aortic dissections, turned out to be slightly underpowered and
there was no difference between the groups in survival at 2
years.22 However, there was a steady trickle of conversion to
TEVAR in the medical therapy group and the tone of recent
presentations suggest that there may be a survival beneﬁt for
the TEVAR group after 5 years. Another trial, the ADSORB trial
aims at comparing TEVAR and best medical therapy to best
medical therapy alone in acute uncomplicated type B aortic
dissections. However, this trial focuses only on surrogate
endpoints, such as false lumen thrombosis, aortic rupture, and
aortic dilatation at one year and no reliable information
regarding survival can be expected.23
In conclusion, the rapidly escalating rate of thoracic aortic
repairs, in the absence of high-level evidence for the mid-
term efﬁcacy of TEVAR, calls for a randomised controlled trial
focussing on survival and full health economic evaluation.FUNDING
Camelia Botnar Arterial Research Foundation.CONFLICT OF INTEREST
None.
REFERENCES
1 Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic
aneurysm and dissection: increasing prevalence and improved
outcomes reported in a nationwide population-based study of
more than 14,000 cases from 1987 to 2002. Circulation
2006;114:2611e8.
2 Sandiford P, Mosquera D, Bramley D. Trends in incidence and
mortality from abdominal aortic aneurysm in New Zealand. Br J
Surg 2011;98:645e51.
3 Anjum A, Powell JT. Is the incidence of abdominal aortic
aneurysm declining in the 21st century? Mortality and hospital
admissions for England & Wales and Scotland. Eur J Vasc
Endovasc Surg 2012;43:161e6.
4 Norman PE, Spilsbury K, Semmens JB. Falling rates of hospi-
talization and mortality from abdominal aortic aneurysms in
Australia. J Vasc Surg 2011;53:274e7.
5 British Heart Foundation. Heart Statistics Publications. http://
www.bhf.org.uk/heart-health/statistics/heartstatistics-
publications.aspx [accessed 01.08.11].
6 Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of
the decline in mortality from acute myocardial infarction in
England between 2002 and 2010: linked national database
study. Br Med J 2012;344:d8059.
7 Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van
Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a pop-
ulation-based study. Surgery 1982;92:1103e8.
8 Clouse WD, Hallett Jr JW, Schaff HV, Gayari MM, Ilstrup DM,
Melton 3rd LJ. Improved prognosis of thoracic aortic aneu-
rysms: a population-based study. J Am Med Assoc 1998;280:
1926e9.
9 Fairman RM, Criado F, Farber M, Kwolek C, Mehta M,
White R, et al. Pivotal results of the Medtronic Vascular Talent
Thoracic Stent Graft System: the VALOR trial. J Vasc Surg
2008;48:546e54.
10 Matsumura JS, Cambria RP, Dake MD, Moore RD, Svensson LG,
Snyder S, et al. International controlled clinical trial of thoracic
endovascular aneurysm repair with the Zenith TX2 endovas-
cular graft: 1-year results. J Vasc Surg 2008;47:247e57
[discussion 57].
11 Makaroun MS, Dillavou ED, Kee ST, Sicard G, Chaikof E,
Bavaria J, et al. Endovascular treatment of thoracic aortic
aneurysms: results of the phase II multicenter trial of the GORE
TAG thoracic endoprosthesis. J Vasc Surg 2005;41:1e9.
12 Goodney PP, Travis L, Lucas FL, Fillinger MF, Goodman DC,
Cronenwett JL, et al. Survival after open versus endovascular
thoracic aortic aneurysm repair in an observational study of
the Medicare population. Circulation 2011;124:2661e9.
13 Anjum A, von Allmen R, Greenhalgh R, Powell JT. Explaining the
decrease in mortality from abdominal aortic aneurysm rupture.
Br J Surg 2012;99:637e45.
14 Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT. 25
year trends in ﬁrst time hospitalisation for acute myocardial
infarction, subsequent short and long term mortality, and the
prognostic impact of sex and comorbidity: a Danish nationwide
cohort study. Br Med J 2012;344:e356.
15 Bandosz P, O’Flaherty M, Drygas W, Rutkowski M, Koziarek J,
Wyrzykowski B, et al. Decline in mortality from coronary heart
disease in Poland after socioeconomic transformation:
modelling study. Br Med J 2012;344:d8136.
R.S. von Allmen et al. 15916 Pounder D, Jones M, Peschel H. How can we reduce the
number of coroner autopsies? Lessons from Scotland and the
Dundee initiative. J R Soc Med 2011;104:19e24.
17 Greenberg RK, O’Neill S, Walker E, Haddad F, Lyden SP,
Svensson LG, et al. Endovascular repair of thoracic aortic
lesions with the Zenith TX1 and TX2 thoracic grafts: interme-
diate-term results. J Vasc Surg 2005;41:589e96.
18 Stone DH, Brewster DC, Kwolek CJ, Lamuraglia GM, Conrad MF,
Chung TK, et al. Stent-graft versus open-surgical repair of the
thoracic aorta: mid-term results. J Vasc Surg 2006;44:1188e97.
19 Leurs LJ, Bell R, Degrieck Y, Thomas S, Hobo R, Lundbom J, et al.
Endovascular treatment of thoracic aortic diseases: combined
experience from the EUROSTAR and United Kingdom Thoracic
Endograft registries. J Vasc Surg 2004;40:670e9 [discussion9e80].
20 Fattori R, Nienaber CA, Rousseau H, Beregi JP, Heijmen R,
Grabenwoger M, et al. Results of endovascular repair of thethoracic aorta with the talent thoracic stent graft: the Talent
Thoracic Retrospective Registry. J Thorac Cardiovasc Surg
2006;132:332e9.
21 Scali ST, Chang CK, Feezor RJ, Hess Jr PJ, Beaver TM, Martin TD,
et al. Preoperative prediction of mortality within 1 year after
elective thoracic endovascular aortic aneurysm repair. J Vasc
Surg 2012;2012(56):1266e73.
22 Nienaber CA, Rousseau H, Eggebrecht H, Kische S, Fattori R,
Rehders TC, et al. Randomized comparison of strategies for
type B aortic dissection: the INvestigation of STEnt Grafts
in Aortic Dissection (INSTEAD) trial. Circulation 2009;120:
2519e28.
23 Brunkwall J, Lammer J, Verhoeven E, Taylor P. ADSORB: a study
on the efﬁcacy of endovascular grafting in uncomplicated acute
dissection of the descending aorta. Eur J Vasc Endovasc Surg
2012;44:31e6.
